---
title: "BTIG maintains a \"Buy\" rating on Intuitive Surgical and raises the target price from $529 to $589"
description: "BTIG maintains a \"Buy\" rating on Intuitive Surgical and raises the target price from $529 to $589"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/262273029.md"
published_at: "2025-10-22T14:57:20.000Z"
---

# BTIG maintains a "Buy" rating on Intuitive Surgical and raises the target price from $529 to $589

BTIG maintains a "Buy" rating on Intuitive Surgical and raises the target price from $529 to $589

### Related Stocks

- [ISRG.US - Intuitive Surgical](https://longbridge.com/en/quote/ISRG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| $100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today | Intuitive Surgical (NASDAQ:ISRG) has delivered an average annual return of 20.44% over the past 20 years, outperforming  | [Link](https://longbridge.com/en/news/271673917.md) |
| Synektik Expands And Extends Distribution Agreement With Intuitive Surgical | Synektik SA :EXTENDS DISTRIBUTION AGREEMENT WITH INTUITIVE SURGICAL TO INCLUDE UKRAINE AND EXTENDS DURATION OF COOPERATI | [Link](https://longbridge.com/en/news/274476098.md) |
| Intuitive Surgical, Inc. $ISRG Position Lessened by Prospera Financial Services Inc | Prospera Financial Services Inc has reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 65.8% in Q3, now hold | [Link](https://longbridge.com/en/news/275886774.md) |
| Unity Software Analysts Slash Their Forecasts After Q4 Results | Unity Software Inc. reported strong Q4 results with adjusted EPS of 24 cents and revenue of $503.08 million, both exceed | [Link](https://longbridge.com/en/news/275767884.md) |
| Intuitive Surgical's Options: A Look at What the Big Money is Thinking | Investors are showing a bullish stance on Intuitive Surgical (NASDAQ:ISRG) with 18 uncommon options trades spotted, spli | [Link](https://longbridge.com/en/news/269757539.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.